Bruker (NASDAQ: BRKR) reported Q3 EPS of $0.63, $0.19 better than the analyst estimate of $0.44. Revenue for the quarter came in at $608.9 million versus the consensus estimate of $574.17 million.

GUIDANCE:

Bruker sees FY2021 EPS of $2.05-$2.09, versus the consensus of $1.93.

For earnings history and earnings-related data on Bruker (BRKR) click here.